Stocks surged for a second day as President Trump appeared to soften his stance over tariffs on imports from China. The ...

After an early wobble, markets resumed rising after Chinese officials contradicted suggestions from President Trump and ...

Just over a month after laying off staff to focus on its lead cancer candidate, ALX Oncology announced that the asset ...

Alán Aspuru-Guzik and his multinational team of mad scientists are combining chemistry, robotics and AI to fight climate ...

A bitter management shake-up. Angry public outbursts. A “narcissistic” pastor whose word is gospel. What in God’s name is happening to the once-mighty pop icon? “Whatever he’s going through, I pray ...

Jason Stacy and Matthew Ellington ... The pharmaceutical company Merck with help from the U.S. Public Health Service produced the film. Measles was declared eliminated from the United States ...

Merck & Co. cut its 2025 earnings outlook, partly to account for recently imposed tariffs that it projects will total $200 million. The projection comes in light of the tariffs implemented so ...

Halozyme is not holding back against Merck & Co. in the companies' injectable Keytruda patent dispute, having now escalated a verbal warning into a lawsuit. In a lawsuit filed Thursday in a New ...

Merck expects $200 million in added tariff costs, primarily impacting gross margins. The company has invested $12 billion since 2017, with another $9 billion planned to expand U.S. manufacturing ...

Merck KGaA is edging closer to the SpringWorks deal, which was first rumoured in February, confirming late-stage negotiations at an estimated price of $47 per share – potentially valuing the ...